蓝帆医疗：关于2026年度使用闲置自有资金购买理财产品的公告

Group 1 - The core point of the article is that Bluestar Medical announced plans to use up to 1.1 billion yuan of idle self-owned funds to purchase high-safety, liquid financial institution wealth management products, with the funds being available for rolling use within a 12-month period from the board's approval [1] Group 2 - The investment is aimed at enhancing the company's financial management and optimizing the use of idle funds [1] - The decision reflects the company's strategy to ensure liquidity while seeking safer investment options [1] - The board's approval is a key step in executing this financial strategy, indicating proactive management of resources [1]